Picture of Dermapharm Holding SE logo

DMP — Dermapharm Holding SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Dermapharm Q2 EBITDA Up 3.7% In Q2 Versus Prior-Year Quarter

Aug 26 (Reuters) - DERMAPHARM HOLDING SE DMPG.DE:

CONFIRMS STABLE BUSINESS DEVELOPMENT IN H1 2025

CONFIRMS OUTLOOK FOR 2025 OVERALL

EBITDA UP 3.7% IN Q2 2025 VERSUS PRIOR-YEAR QUARTER

Source text: ID:nEQ4RDzsZa

Further company coverage: DMPG.DE

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Dermapharm Holding SE

See all news